Kali-Extracts Announces Cannabis Treatment For $9 Billion Epilepsy Market Under Development
KALY plans to publish an online presentation with more detail on each of the treatment developments later this month.
Read More
Category: Biomedical
Important Changes to Aphria Medical Products
Aphria seeks implementing several changes, including changes to our labels, our oil products, and the medical cannabis product selection process.
Read More
International Cannabis Completes Strategic Investment Into Pioneering Biosynthesis Cannabinoid Company; Formed by Leading Group of MIT/Harvard Healthcare Professionals
Biotii is actively pursuing genetically engineered microorganisms that express cannabinoid profiles identical to those found in nature, at a fraction of the cost of current cannabis production methods and with more consistent production quality.
Read More
Kali-Extracts Announces Developing Cannabis Pain Management Treatment For $83 Billion Market Specifically Targeting Cancer
KALY is developing a proprietary extract that improves upon the cannabis treatments currently approved by the FDA.
Read More
KALY – Kali-Extracts Announces 25 mg CBD Extract Formulation For $600 Million Cannabis Beverage Market
KALY indicates its formulation will be on shelves infused into its first beverage within the next 30 days.
Read MoreGET LISTED
